The present invention relates to new antibiotic macrolide compounds of the general formula I:
with improved activity, to medicaments comprising such antibiotics, and to the use of such antibiotics for the treatment of infectious diseases, inflammatory diseases and human diseases or disorders which can be ameliorated by inhibition human phospdiesterases.
The novel 2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-propanol derivertives have antifungal activities, and they are used for preventing or treating infectious diseases caused by fungi.
Die vorliegende Erfindung betrifft Katalysatoren für Kondensations-, Additions- und Veresterungsreaktionen ein Verfahren zur Herstellung dieser Katalysatoren und deren Verwendung zur Herstellung von Bisphenolen.